Metformin in Kidney Disease

NCT02252081 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

125

Enrollment

FED

Sponsor class

Conditions

Chronic Kidney Disease
Cardiovascular Disease
Metabolic Syndrome

Interventions

DRUG: metformin
DRUG: Placebo

Sponsor

VA Office of Research and Development